Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Endo to Announce First Quarter 2016 Financial Results on May 5, 2016

Endo to Announce First Quarter 2016 Financial Results on May 5, 2016

Endo to Announce First Quarter 2016 Financial Results on May 5, 2016

Canada NewsWire

DUBLIN, April 22, 2016 /CNW/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its first quarter 2016 financial results after the close of the U.S. financial markets on May 5, 2016 and members of its senior management team will host a conference call and webcast at 4:30 p.m. ET that day.

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 91618118. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from May 5, 2016 at 7:30 p.m. ET until 11:59 p.m. ET on May 19, 2016 by dialing (855) 859-2056 (U.S./Canada) or (404) 537-3406 (International) and entering the passcode 91618118. 

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on May 19, 2016. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc
Endo International plc (NASDAQ: ENDP) (TSX: ENL) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

                                     

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-first-quarter-2016-financial-results-on-may-5-2016-300255900.html

SOURCE Endo International plc

Endo International plc: Investors/Media: Keri P. Mattox, (484) 216-7912, or Media: Heather Zoumas-Lubeski, (484) 216-6829, http://www.endo.comCopyright CNW Group 2016



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today